Table 1.
Baseline characteristics of study patients
| Characteristics | CLD patients (n = 142) | HCC patients (n = 304) | p value |
|---|---|---|---|
| Age (year)a | 65 (14) | 72 (14) | < 0.001 |
| Sex (male/female) | 84/58 | 213/91 | 0.023 |
| Etiology (HBV/HCV/Others) | 26/69/47 | 34/156/114 | 0.116 |
| Liver damage (CH/LC) | 66/76 | 52/252 | < 0.001 |
| AFP (ng/mL)a | 3.8 (3.1) | 15.7 (112.7) | < 0.001 |
| DCP (mAU/mL)a | 20 (9) | 93 (1140) | < 0.001 |
| AST (IU/L)a | 27 (23) | 47 (44) | < 0.001 |
| ALT (IU/L)a | 22 (28) | 35 (32) | < 0.001 |
| ALB (g/dL)a | 4.3 (0.5) | 3.7 (0.7) | < 0.001 |
| T-Bil (mg/dL)a | 0.9 (0.5) | 0.9 (0.6) | 0.612 |
| PLT (× 104/μL)a | 14.2 (10.2) | 11.9 (9.7) | < 0.001 |
| PT (%)a | 99 (21) | 93 (24) | 0.014 |
| Child-Pugh (A/B/C) | 125/13/4 | 246/49/9 | 0.137 |
a Data are expressed as median (interquartile range)
Abbreviations, CLD chronic liver disease, HCC hepatocellular carcinoma, HBV hepatitis B virus, HCV hepatitis C virus, CH chronic hepatitis, LC liver cirrhosis, AFP alpha-fetoprotein, DCP des-gamma-carboxy prothrombin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALB albumin, T-Bil total bilirubin, PLT platelet, PT prothrombin time